Caruso G, Passàli F M, Salerni L, Molinaro G, Messina M
ENT Department, University of Siena, Siena, Italy.
Int J Pediatr Otorhinolaryngol. 2009 Dec;73 Suppl 1:S38-41. doi: 10.1016/S0165-5876(09)70008-4.
Lymph nodal disease is one of the most common manifestations of head and neck tuberculosis and is particularly frequent in paediatric patients with an increasing incidence in the last decade. It may represent the manifestation of a systemic tuberculous disease or a clinical entity specific of the neck. Aim of this paper is to retrospectively analyse mycobacterial cervical adenopathies observed in two Paediatric European Centers between 1986 and 2004 and the outcomes of medical or surgical treatment.
353 children were examined for mycobacterial cervical lymphadenopaties since January 1986 to December 2004. Demografic data about the sample are showed. The retrospective evaluation of the sample underlined distribution according to etiologic patterns, head and neck adenopathies localization. Previous or simultaneous medical or surgical treatment were analyzed. Statistical analysis with Chi Square test was performed.
281 (79.60%) cases showed a higher localization and 72 (20.40%) a lower localization. In relation to the etiological agent, 8 (2.27%) Mycobacterium tuberculosis (MTB) and 222 (62.89%) mycobacteria other than tuberculosis (MOTT) lymphadenopaties were observed in the upper localization as opposed to 21 (5.95%) MTB and 39 (11.05%) MOTT in the lower plane. Two (0.56%) were detected as upper lymph nodal tumefaction in the median line. In 86 (24.36%) cases at the MRI the so-called "iceberg effect" was noted. 163 (62.45%) patients underwent primary excisional biopsy whereas 74 (28.35%) underwent exeresis after other unsuccessfull therapies, 9 underwent only drainage, and 15 drainage with subsequent antibiotic therapy. Number of relapses after surgery was 16 (6.13%).
A not homogeneous therapeutic approach to the mycobacterial cervical adenitis arises from literature and WHO guidelines does not give indications for the treatment of the cervical pattern. A therapeutic strategy based on the etiology is mandatory. In case of MBT adenopathy the therapy of choice includes the association, in variable way, of different chemotherapic drugs; surgery is reserved to advanced cases. Conversely, in cases of MOTT adenopathy, surgery is the treatment of choice.
淋巴结疾病是头颈部结核最常见的表现之一,在儿科患者中尤为常见,且在过去十年中发病率不断上升。它可能是全身性结核病的表现,也可能是颈部特有的临床实体。本文旨在回顾性分析1986年至2004年期间在两个欧洲儿科中心观察到的分枝杆菌性颈淋巴结炎以及药物或手术治疗的结果。
自1986年1月至2004年12月,对353名儿童进行了分枝杆菌性颈淋巴结病检查。展示了样本的人口统计学数据。对样本的回顾性评估强调了根据病因模式、头颈部淋巴结病定位的分布情况。分析了先前或同时进行的药物或手术治疗。采用卡方检验进行统计分析。
281例(79.60%)表现为高位病变,72例(20.40%)表现为低位病变。就病原体而言,在上位病变中观察到8例(2.27%)结核分枝杆菌(MTB)和222例(62.89%)非结核分枝杆菌(MOTT)淋巴结病,而在低位病变中分别为21例(5.95%)MTB和39例(11.05%)MOTT。2例(0.56%)在中线处被检测为高位淋巴结肿大。在86例(24.36%)病例的MRI检查中发现了所谓的“冰山效应”。163例(62.45%)患者接受了初次切除活检,74例(28.35%)在其他治疗未成功后接受了切除术,9例仅接受了引流,15例进行了引流并随后接受了抗生素治疗。术后复发16例(6.13%)。
文献中出现了对分枝杆菌性颈淋巴结炎的治疗方法不一致的情况,世界卫生组织的指南也未给出颈部模式治疗的指征。基于病因的治疗策略是必不可少的。对于MTB淋巴结病,首选治疗方法包括以不同方式联合使用不同的化疗药物;手术仅适用于晚期病例。相反,对于MOTT淋巴结病,手术是首选治疗方法。